2021 American Society of Hematology Annual Meeting*

Download All
December 11-14, 2021; Atlanta, Georgia
Expert faculty review and share their insights and perspectives on key findings in acute and chronic leukemias presented at the 2021 ASH Annual Meeting.
B Douglas Smith
B. Douglas Smith, MD
Eunice S. Wang, MD

Acute and Chronic Leukemias

Slidesets Pooled Analysis of Impact of TP53 Mutations on Efficacy of Venetoclax + Azacitidine in Patients With AML and Poor-Risk Cytogenetics
Slidesets ASCEMBL: 48-Wk Update of Results From the Phase III Study of STAMP Inhibitor Asciminib vs Bosutinib for CML-CP Previously Treated With ≥2TKIs
Slidesets CPX-351 and HMA + Venetoclax as Frontline Therapy in AML: A Retrospective Comparative Analysis
Slidesets Venetoclax/Decitabine for Young Adults With Newly Diagnosed ELN Adverse-Risk AML: Phase II Trial Interim Analysis
Slidesets GMALL 08/2013: First Results From the Risk-Adapted, MRD-Stratified Trial in Adults With Newly Diagnosed ALL/LBL
Slidesets Evaluation of Quizartinib With Venetoclax and Decitabine Therapy in Patients With Newly Diagnosed or R/R FLT3-Mutated AML
Slidesets Combination Therapy With Azacitidine, Venetoclax, and Magrolimab in Newly Diagnosed and Relapsed/Refractory AML
Slidesets Low-Dose Dasatinib vs Standard-Dose Dasatinib in Newly Diagnosed CP-CML: A Propensity Score Analysis
Slidesets Phase Ib Study of Gilteritinib Combined With Venetoclax for R/R Acute Myeloid Leukemia
Slidesets AGILE: Phase III Trial of Ivosidenib + Azacitidine vs Placebo + Azacitidine in Newly Diagnosed IDH1-Mutated Acute Myeloid Leukemia
Slidesets LACEWING: Phase III Study of Gilteritinib + Azacitidine vs Azacitidine for Patients With Newly Diagnosed FLT3-Mutated AML Ineligible for Intensive Induction Chemotherapy

Expert faculty review and share their insights and perspectives on key studies on the management of acute and chronic leukemias presented at the Hematology 2021 annual meeting.

B Douglas Smith B. Douglas Smith, MD Eunice S. Wang, MD Physicians: maximum of 1.0 AMA PRA Category 1 Credit™ Released: April 6, 2022 Expired: No longer available for credit
Provided by Clinical Care Options, LLC
Contact Info

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Supported by educational grants from
AbbVie
AstraZeneca
Daiichi Sankyo, Inc.
GlaxoSmithKline
Incyte Corporation
Jazz Pharmaceuticals, Inc.
Merck Sharp & Dohme Corp.
Novartis Pharmaceuticals Corporation

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings